A BILL 
To expand and improve the programs and activities of the 
Department of Health and Human Services for aware-
ness, education, research, surveillance, diagnosis, and 
treatment concerning rare diseases and conditions. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Rare disease Advance-
4
ment, surveillance Research, and Education Act of 2019’’ 
5
or the ‘‘RARE Act of 2019’’. 
6
20:32 Sep 09, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
2 
•HR 4228 IH
SEC. 2. NIH RARE DISEASE REGIONAL CENTERS OF EXCEL-
1
LENCE. 
2
Paragraph (1) of section 402A(a) of the Public 
3
Health Service Act (42 U.S.C. 282a(a)) is amended by 
4
adding at the end the following: ‘‘In addition to the 
5
amounts authorized to be appropriated by the preceding 
6
sentence, there are authorized to be appropriated such 
7
sums as may be necessary for each of fiscal years 2020 
8
through 2024 for carrying out section 481A (relating to 
9
rare disease regional centers of excellence).’’. 
10
SEC. 3. CDC SURVEILLANCE OF RARE DISEASES AND CON-
11
DITIONS. 
12
Title III of the Public Health Service Act is amended 
13
by inserting after section 317T of such Act (42 U.S.C. 
14
247b–22) the following: 
15
‘‘SEC. 317U. CDC SURVEILLANCE OF RARE DISEASES AND 
16
CONDITIONS. 
17
‘‘(a) IN GENERAL.—The Secretary may, as appro-
18
priate— 
19
‘‘(1) enhance and expand infrastructure and ac-
20
tivities to track the epidemiology of up to 4 rare dis-
21
eases and conditions selected under subsection 
22
(c)(1); and 
23
‘‘(2) incorporate information obtained through 
24
such activities into an integrated surveillance system 
25
00:20 Sep 07, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
3 
•HR 4228 IH
to be known as the National Rare Disease or Condi-
1
tion Surveillance System. 
2
‘‘(b) RESEARCH.—The Secretary shall ensure that 
3
the National Rare Disease or Condition Surveillance Sys-
4
tem is designed in a manner that provides information 
5
that facilitates further research on rare diseases and con-
6
ditions. 
7
‘‘(c) CONTENT.—In carrying out subsection (a), the 
8
Secretary— 
9
‘‘(1) shall select up to 4 rare diseases and con-
10
ditions that are determined by the Secretary to 
11
have— 
12
‘‘(A) a high rate of mortality or morbidity; 
13
or 
14
‘‘(B) potential for meaningful research and 
15
treatment; 
16
‘‘(2) shall provide for the collection and storage 
17
of information on the incidence and prevalence of 
18
such rare diseases and conditions in the United 
19
States; 
20
‘‘(3) to the extent practicable, shall provide for 
21
the collection and storage of other available informa-
22
tion on such rare diseases and conditions, including 
23
information related to persons living with such a 
24
rare disease or condition who choose to participate 
25
00:20 Sep 07, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
4 
•HR 4228 IH
in surveillance activities, and including information 
1
on— 
2
‘‘(A) demographics, such as age, race, eth-
3
nicity, sex, geographic location, family history, 
4
and other information, as appropriate; 
5
‘‘(B) risk factors that may be associated 
6
with the rare disease or condition, such as ge-
7
netic and environmental risk factors and other 
8
information, as appropriate; and 
9
‘‘(C) diagnosis and progression markers; 
10
‘‘(4) to the extent practicable, shall provide for 
11
the collection and storage of information relevant to 
12
analysis on such rare diseases and conditions, such 
13
as information concerning— 
14
‘‘(A) the natural history of the diseases 
15
and conditions; 
16
‘‘(B) the prevention of the disease or con-
17
dition, including secondary diseases and condi-
18
tions; 
19
‘‘(C) the detection, management, and 
20
treatment approaches for the diseases and con-
21
ditions; and 
22
‘‘(D) the development of outcomes meas-
23
ures; and 
24
00:20 Sep 07, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
5 
•HR 4228 IH
‘‘(5) may address issues identified during the 
1
consultation process under subsection (d). 
2
‘‘(d) CONSULTATION.—In carrying out this section, 
3
the Secretary shall consult with individuals with appro-
4
priate expertise, which may include— 
5
‘‘(1) epidemiologists with experience in disease 
6
surveillance; 
7
‘‘(2) representatives of national voluntary 
8
health associations that— 
9
‘‘(A) focus on rare diseases or conditions; 
10
and 
11
‘‘(B) have demonstrated experience in re-
12
search, care, or patient services; 
13
‘‘(3) health information technology experts or 
14
other information management specialists; 
15
‘‘(4) clinicians with expertise in rare diseases or 
16
conditions; 
17
‘‘(5) research scientists with expertise in rare 
18
diseases or conditions, or experience conducting 
19
translational research or utilizing surveillance sys-
20
tems for scientific research purposes; and 
21
‘‘(6) patients and caregivers of patients with 
22
rare diseases or conditions. 
23
‘‘(e) GRANTS.—The Secretary may award grants to, 
24
or enter into contracts or cooperative agreements with, 
25
00:20 Sep 07, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
6 
•HR 4228 IH
public or private nonprofit entities to carry out activities 
1
under this section. 
2
‘‘(f) COORDINATION WITH OTHER FEDERAL, STATE, 
3
AND LOCAL AGENCIES.—Subject to subsection (h), the 
4
Secretary shall— 
5
‘‘(1) make information and analysis in the Na-
6
tional Rare Disease or Condition Surveillance Sys-
7
tem available, as appropriate— 
8
‘‘(A) to Federal departments and agencies, 
9
such as the National Institutes of Health and 
10
the Department of Veterans Affairs; and 
11
‘‘(B) to State and local agencies; and 
12
‘‘(2) identify, build upon, leverage, and coordi-
13
nate among existing data and surveillance systems, 
14
surveys, registries, and other Federal public health 
15
infrastructure, wherever practicable. 
16
‘‘(g) PUBLIC ACCESS.—Subject to subsection (h), the 
17
Secretary shall ensure that information and analysis in the 
18
National Rare Disease or Conditions Surveillance System 
19
are available, as appropriate, to the public, including re-
20
searchers. 
21
‘‘(h) PRIVACY.—The Secretary shall ensure that in-
22
formation and analysis in the National Rare Disease or 
23
Condition Surveillance System are made available only to 
24
the extent permitted by applicable Federal and State law, 
25
00:20 Sep 07, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
7 
•HR 4228 IH
and in a manner that protects personal privacy, to the ex-
1
tent required by applicable Federal and State privacy law, 
2
at a minimum. 
3
‘‘(i) SUPPLEMENT NOT SUPPLANT.—The activities 
4
under this section may supplement, but shall not supplant, 
5
any activities with respect to spina bifida, muscular dys-
6
trophy, or fragile X syndrome that are ongoing as of the 
7
date of enactment of this section. 
8
‘‘(j) REPORTS.— 
9
‘‘(1) REPORT
ON
INFORMATION
AND
ANAL-
10
YSES.—Not later than 2 years after the date on 
11
which any system is established under this section, 
12
the Secretary shall submit an interim report to the 
13
Committee on Health, Education, Labor, and Pen-
14
sions of the Senate and the Committee on Energy 
15
and Commerce of the House of Representatives re-
16
garding aggregate information collected pursuant to 
17
this section and epidemiological analyses, as appro-
18
priate. Such report shall be posted on the Internet 
19
website of the Department of Health and Human 
20
Services and shall be updated biennially. 
21
‘‘(2) IMPLEMENTATION
REPORT.—Not later 
22
than 4 years after the date of the enactment of this 
23
section, the Secretary shall submit a report to the 
24
00:20 Sep 07, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
8 
•HR 4228 IH
Congress concerning the implementation of this sec-
1
tion. Such report shall include information on— 
2
‘‘(A) the development and maintenance of 
3
the National Rare Disease or Condition Surveil-
4
lance System; 
5
‘‘(B) the type of information collected and 
6
stored in the surveillance system; 
7
‘‘(C) the use and availability of such infor-
8
mation, including guidelines for such use; and 
9
‘‘(D) the use and coordination of databases 
10
that collect or maintain information on rare dis-
11
eases or conditions. 
12
‘‘(k) DEFINITIONS.—In this section: 
13
‘‘(1) NATIONAL VOLUNTARY HEALTH ASSOCIA-
14
TION.—The term ‘national voluntary health associa-
15
tion’ means a national nonprofit organization with 
16
chapters, other affiliated organizations, or networks 
17
in States throughout the United States with experi-
18
ence serving the population of individuals with a 
19
rare disease or condition and have demonstrated ex-
20
perience in rare disease or condition research, care, 
21
and patient services. 
22
‘‘(2) RARE.—The term ‘rare’, with respect to a 
23
disease or condition, means having a prevalence of 
24
fewer than 200,000 individuals in the United States. 
25
00:20 Sep 07, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
9 
•HR 4228 IH
‘‘(l) AUTHORIZATION
OF
APPROPRIATIONS.—To 
1
carry out this section, there are authorized to be appro-
2
priated $10,000,000 for each of fiscal years 2020 through 
3
2025.’’. 
4
SEC. 4. INCREASING HEALTH PROFESSIONALS’ AWARENESS 
5
OF RARE DISEASES. 
6
(a) IN GENERAL.—The Director of the Agency for 
7
Healthcare Research and Quality shall expand and inten-
8
sify the activities of the Agency to increase the awareness 
9
and knowledge of health care providers about rare diseases 
10
and conditions. 
11
(b) DEFINITION.—In this section, the term ‘‘rare dis-
12
eases and conditions’’, with respect to a disease or condi-
13
tion, means having a prevalence of fewer than 200,000 
14
individuals in the United States. 
15
SEC. 5. REPORT. 
16
(a) IN GENERAL.—The Secretary of Health and 
17
Human Services shall seek to enter into an arrangement 
18
with the National Academies (or another appropriate enti-
19
ty if the National Academies decline) to update and repub-
20
lish, by not later than 3 years after the date of enactment 
21
of this Act, the 2010 report of the National Academies 
22
entitled ‘‘Rare Diseases and Orphan Products: Accel-
23
erating Research and Development’’. 
24
00:20 Sep 07, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
10 
•HR 4228 IH
(b) AUTHORIZATION OF APPROPRIATIONS.—To carry 
1
out this section, there is authorized to be appropriated 
2
$1,000,000. 
3
Æ 
00:20 Sep 07, 2019
H4228
jspears on DSK3GMQ082PROD with BILLS
